Abstract
Computed tomography (CT) has evolved into a powerful diagnostic tool, and it is impossible to imagine current clinical practice without CT imaging. Because of its widespread availability, ease of clinical application, superb sensitivity for the detection of coronary artery disease, and noninvasive nature, CT has become a valuable tool within the armamentarium of cardiologists. In the past few years, numerous technological advances in CT have occurred, including dual-energy CT, spectral CT, and CT-based molecular imaging. By harnessing the advances in technology, cardiac CT has advanced beyond the mere evaluation of coronary stenosis to an imaging tool that permits accurate plaque characterization, assessment of myocardial perfusion, and even probing of molecular processes that are involved in coronary atherosclerosis. Novel innovations in CT contrast agents and pre-clinical spectral CT devices have paved the way for CT-based molecular imaging. (J Am Coll Cardiol Img 2015;8:710-23) (C) 2015 by the American College of Cardiology Foundation.
Original language | English |
---|---|
Pages (from-to) | 710-723 |
Number of pages | 14 |
Journal | JACC: Cardiovascular Imaging |
Volume | 8 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2015 |
Keywords
- dual-energy CT
- molecular CT imaging
- spectral CT
- CORONARY-ARTERY-DISEASE
- BISMUTH SULFIDE NANOPARTICLES
- RISK-ASSESSMENT STRATEGIES
- PITCH SPIRAL ACQUISITION
- MYOCARDIAL-PERFUSION
- ITERATIVE RECONSTRUCTION
- DIAGNOSTIC PERFORMANCE
- SINGLE-SOURCE
- ATHEROSCLEROTIC PLAQUES
- CONTRAST AGENT